Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Fenofibrate in Ulcerative Colitis [Phase 2, Phase 3]
A Phase 2/3 trial evaluating fenofibrate for ulcerative colitis is currently recruiting, sponsored by Tanta University.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis [NA]
A clinical trial update describing a study that evaluates fecal transplant and dietary changes to assess disease activity in patients with n…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease [Phase 3]
Phase 3 trial evaluating long-term safety of Vedolizumab given subcutaneously in adults with Ulcerative Colitis and Crohn's Disease; study c…
-
FDA approval · 2025-04-03FDA Approved: BALSALAZIDE DISODIUM — Original Application (Carnegie Pharmaceuticals, LLC)
FDA approved the original ANDA for balsalazide disodium as a generic treatment for ulcerative colitis, manufactured by Carnegie Pharmaceutic…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab [Phase 4]
A Phase 4 study assessing the immunogenicity of a herpes zoster subunit vaccine in inflammatory bowel disease patients treated with vedolizu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Carotegrast Methyl in Ulcerative Colitis [Phase 4]
Phase 4 study evaluating Carotegrast Methyl for Ulcerative Colitis has completed.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies [NA]
A clinical trial is evaluating the impact of fecal transplant and dietary changes on disease activity in ulcerative colitis patients receivi…
-
FDA approval · 2025-04-01FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab (Stelara) by Janssen Biotech, Inc.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Proof of Concept Human Study: Dietary Intervention to Modify Intestinal Inflammation in IBD [NA]
A proof-of-concept human trial evaluating a dietary intervention to reduce intestinal inflammatory activity in inflammatory bowel disease is…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: A Study to Evaluate Non-invasive Measurements of the Inflammatory Status in Patients with IBD [NA]
A clinical trial is evaluating non-invasive measurements of inflammatory status in patients with inflammatory bowel disease, including ulcer…
-
FDA approval · 2025-03-26FDA Approved: RINVOQ — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Rinvoq (upadacitinib) from AbbVie, resulting in labeling changes to the product.
-
FDA label_change · 2025-03-26FDA Approved: RINVOQ — Supplemental Application (AbbVie Inc.)
FDA approved AbbVie’s supplemental application for Rinvoq (upadacitinib), resulting in a labeling update for the product.
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: The Bacterial Secretome in IBD
This clinical trial update notes that a study on the bacterial secretome in inflammatory bowel diseases has completed. The sponsor is the Me…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC) [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and long-term safety of oral ozanimod in Chinese participants with moderately to severely a…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Genome Analysis Across Populations in Inflammatory Bowel Disease
A clinical trial is recruiting to study genome analysis across populations in inflammatory bowel disease, including ulcerative colitis and C…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002) [Phase 1]
Phase 1 study of MK-6194 (PT101) in active ulcerative colitis has completed; results have been posted.
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC) [Phase 1]
This update outlines a Phase 1 clinical trial of LIV001 for mild-to-moderate active ulcerative colitis, with status not yet recruiting. No r…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)
Results have been posted for Pfizer's infliximab biosimilar trial evaluating its use in Crohn's disease and ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease [Phase 4]
Phase 4 clinical trial update reporting identification of predictive biomarkers for response to biologic therapies and tofacitinib in inflam…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events [Phase 4]
Phase 4 clinical trial evaluating the effects of tofacitinib on coagulation, platelet function, and thromboembolic events in patients with u…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: An Early Phase 2 Clinical Study of KSP-0243 [Phase 2]
An early Phase 2 study of KSP-0243 for ulcerative colitis has completed.
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation
A prospective study aims to identify predictive biomarkers that distinguish postoperative recurrence and complications in ulcerative colitis…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Ibd CAncer and seRious Infections in France (I-CARE 2)
This clinical trial update indicates ongoing recruitment for I-CARE 2 in France. The study examines cancer risk and serious infections in in…
-
FDA approval · 2025-03-13FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC, updating the product’s labeling a…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: The Associations of Microribonucleic Acid Gene Polymorphisms With the Risk of Ulcerative Colitis
This clinical trial update reports on completed research examining whether microRNA gene polymorphisms are associated with the risk of devel…